Do dose-volume metrics predict pulmonary function changes in lung irradiation?ALLEN, A. M; HENNING, G. T; TEN HAKEN, R. K et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 4, pp 921-929, issn 0360-3016, 9 p.Article

Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cellsLIANG, Chia-Hua; SHIU, Li-Yen; CHANG, Li-Ching et al.Molecular nutrition & food research (Print). 2007, Vol 51, Num 8, pp 999-1005, issn 1613-4125, 7 p.Article

PET with ¹⁸F-fluorodeoxyglucose for staging of non-small cell lung cancer: Evidence-based recommendations and cost-effectivenessWABIR, W. A; DIETLEIN, M; HELLWIG, D et al.Nuclear-Medizin. 2003, Vol 42, Num 4, pp 135-144, issn 0029-5566, 10 p.Article

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancerROSELL, Rafael; SCAGLIOTTI, Giorgio; BONI, Corrado et al.Oncogene (Basingstoke). 2003, Vol 22, Num 23, pp 3548-3553, issn 0950-9232, 6 p.Article

Equivalent outcome of patients with clinical stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resectionTAYLOR, Noah A; LIAO, Zhongxing X; FOSSELLA, Frank V et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 1, pp 204-212, issn 0360-3016, 9 p.Conference Paper

Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLCLANGER, Corey J.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 3, pp 991-1002, issn 0360-3016, 12 p.Conference Paper

Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLCMULEY, Thomas; DIENEMANN, Hendrik; EBERT, Werner et al.Anticancer research. 2003, Vol 23, Num 5B, pp 4085-4093, issn 0250-7005, 9 p.Article

The Hsp90 inhibitor IPI-504 rapidly lowers EML4―ALK levels and induces tumor regression in ALK-driven NSCLC modelsNORMANT, E; PAEZ, G; PALOMBELLA, V. J et al.Oncogene (Basingstoke). 2011, Vol 30, Num 22, pp 2581-2586, issn 0950-9232, 6 p.Article

Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutantsCHEN, Y.-R; FU, Y.-N; LIN, C.-H et al.Oncogene (Basingstoke). 2006, Vol 25, Num 8, pp 1205-1215, issn 0950-9232, 11 p.Article

Oestrogen receptor β in NSCLC ― prevalence, proliferative influence, prognostic impact and smokingKARLSSON, Christina; HELENIUS, Gisela; FERNANDES, Oswaldo et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2012, Vol 120, Num 6, pp 451-458, issn 0903-4641, 8 p.Article

XQ2, a Novel TPZ Derivative, Induced G2/M Phase Arrest and Apoptosis under Hypoxia in Non-Small Cell Lung Cancer CellsLOU, Jianshu; ZHOU, Xinglu; WENG, Qinjie et al.Bioscience, biotechnology, and biochemistry. 2010, Vol 74, Num 6, pp 1181-1187, issn 0916-8451, 7 p.Article

Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lungSY, S. M.-H; WONG, N; LEE, T.-W et al.European journal of cancer (1990). 2004, Vol 40, Num 7, pp 1082-1094, issn 0959-8049, 13 p.Article

Fludarabine combined with radiotherapy in patients with locally advanced NSCLC lung carcinoma: a phase I studyNITSCHE, Mirko; CHRISTIANSEN, Hans; LEDERER, Katinka et al.Journal of cancer research and clinical oncology. 2012, Vol 138, Num 7, pp 1113-1120, issn 0171-5216, 8 p.Article

AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell linesPUGLISI, M; THAVASU, P; STEWART, A et al.Lung cancer. 2014, Vol 85, Num 2, pp 141-146, issn 0169-5002, 6 p.Article

Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancerJAKOBSEN, Jan Nyrop; SANTONI-RUGIU, Eric; SØRENSEN, Jens Benn et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 1, pp 131-137, issn 0344-5704, 7 p.Article

Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patientsKUIPER, J. L; HEIDEMAN, D. A. M; THUNNISSEN, E et al.Lung cancer. 2014, Vol 85, Num 1, pp 19-24, issn 0169-5002, 6 p.Article

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancerCIHORIC, N; SAVIC, S; TAPIA, C et al.British journal of cancer. 2014, Vol 110, Num 12, pp 2914-2922, issn 0007-0920, 9 p.Article

Response to pemetrexed rechallenge after acquired resistance of EGFR-TKI in a patient with advanced NSCLCSHUAI LI; FANGYU ZHOU; SHENGXIANG REN et al.Lung cancer. 2014, Vol 84, Num 2, pp 203-205, issn 0169-5002, 3 p.Article

Strategies for co-targeting the PI3K/AKT/mTOR pathway in NSCLCHEAVEY, Susan; O'BYRNE, Kenneth J; GATELY, Kathy et al.Cancer treatment reviews. 2014, Vol 40, Num 3, pp 445-456, issn 0305-7372, 12 p.Article

A phase I pharmacokinetic study of matuzumab in combination with paclitaxel in patients with EGFR-expressing advanced non-small cell lung cancerHARTMANN, J. T; KOLLMANNSBERGER, C; CASCORBI, I et al.Investigational new drugs. 2013, Vol 31, Num 3, pp 661-668, issn 0167-6997, 8 p.Article

A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research GroupKONTOPODIS, Emmanouil; HATZIDAKI, Dora; VARTHALITIS, Ioannis et al.Journal of chemotherapy (Testo stampato). 2013, Vol 25, Num 1, pp 49-55, issn 1120-009X, 7 p.Article

Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancerYAN WANG; QIANZE DONG; YUAN MIAO et al.Lung cancer. 2013, Vol 81, Num 2, pp 266-272, issn 0169-5002, 7 p.Article

Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinibBOS, M; GARDIZI, M; KOBE, C et al.Lung cancer. 2013, Vol 81, Num 1, pp 142-143, issn 0169-5002, 2 p.Article

Decrease of PDSS2 expression, a novel tumor suppressor, in non-small cell lung cancerPING CHEN; JUN YU; KNECHT, Jodi et al.Cancer epidemiology (Print). 2013, Vol 37, Num 2, pp 166-171, issn 1877-7821, 6 p.Article

Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594HOANG, Tien; DAHLBERG, Suzanne E; SCHILLER, Joan H et al.Lung cancer. 2013, Vol 81, Num 1, pp 47-52, issn 0169-5002, 6 p.Article